Long-term outcomes with rituximab as add-on therapy in severe childhood-onset lupus nephritis.

Eugene Yu Hin ChanSze-Wa WongFiona Fung-Yee LaiTsz-Wai HoPak-Chiu TongWai-Ming LaiAlison Lap-Tak MaDesmond Yat-Hin Yap

Published in: Pediatric nephrology (Berlin, Germany) (2023)

Add-on rituximab is an effective and safe rescue therapy for cLN patients with life-/organ-threatening manifestations or treatment-resistance. A higher resolution version of the Graphical abstract is available as Supplementary information.

Keyphrases

diffuse large b cell lymphoma
hodgkin lymphoma
early onset
healthcare
single molecule
young adults
early life
social media
mesenchymal stem cells
bone marrow
drug induced